RGT Argent BioPharma Limited

—Mkt Cap: —P/E: —

Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and the United King…

Key Statistics

Company
Market Cap—
Enterprise Value8.70M USD
Revenue (TTM)111.39K USD
Gross Profit308.45K USD
Net Income (TTM)-12.33M USD
Revenue/Share0.0020 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINAU0000326647
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.71
EV/Revenue78.14
P/S19.74
P/B-0.32
EPS (TTM)-0.09
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin76.50%
Oper. Margin43133.83%
EBITDA Margin0.00%
Profit Margin-3058.43%
ROE206.77%
ROA-723.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.78M USD
CapEx (TTM)1.54K USD
FCF Margin-1332.46%
FCF Yield—
Net Debt6.53M USD
Net Debt/EBITDA-1.28
Balance Sheet
Debt/Equity-0.96
Current Ratio0.05
Quick Ratio0.04
Book Value/Sh-0.09 AUD
Cash/Share0.0010 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateOct 30, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.117.86M
Float40.11M
Insiders62.59%
Institutions0.00%
Technical
SMA 500.0333 AUD
SMA 2000.0428 AUD
Beta0.52
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)81.72K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—